Tetsushi Yoshikawa
Overview
Explore the profile of Tetsushi Yoshikawa including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
277
Citations
2835
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sugita H, Mori Y, Yoshikawa T, Kondo Y
Allergol Immunopathol (Madr)
. 2025 Mar;
53(2):89-99.
PMID: 40088027
Background: Walnut () frequently triggers nut allergies in the United Kingdom and in the United States, with increasing cases in Japan. While oral food challenges (OFCs) are the definitive method...
2.
Morioka I, Kakei Y, Imai T, Fujioka K, Takahashi N, Yoshikawa T, et al.
J Clin Virol
. 2025 Mar;
177:105778.
PMID: 40086367
Objective: To evaluate the long-term hearing outcomes of infants with symptomatic congenital cytomegalovirus (CMV) disease who received 16 mg/kg of oral valganciclovir (VGCV) twice daily for six months. Study Design:...
3.
Ikuse T, Aizawa Y, Kamata K, Thein K, Lasham D, Tun S, et al.
IJID Reg
. 2025 Mar;
14:100589.
PMID: 40066346
Objectives: In developing countries, acute gastroenteritis (AGE) is a leading cause of death in children younger than 5 years. In Myanmar, no comprehensive study has been done to investigate the...
4.
Okabe H, Sato M, Norito S, Yaginuma K, Saito Y, Yoshikawa T, et al.
Fukushima J Med Sci
. 2025 Mar;
PMID: 40058811
Human herpesvirus 7 (HHV-7) is ubiquitous and infects most children. Severe HHV-7 infection was considered to be rare. In this case series, we report the clinical findings and clinical courses...
5.
Kawamura Y, Mizutani Y, Asakura M, Nagao R, Ueda A, Watanabe H, et al.
Pediatr Int
. 2025 Jan;
67(1):e15865.
PMID: 39812112
No abstract available.
6.
Miyata M, Kojima A, Kawai Y, Uchida H, Boda H, Ishihara N, et al.
Hum Genome Var
. 2025 Jan;
12(1):2.
PMID: 39762237
UBA1 is an E1 ubiquitin-activating enzyme that initiates the ubiquitylation of target proteins and is thus a key component of the ubiquitin signaling pathway. Three disorders are associated with pathogenic...
7.
Mihara Y, Nakayama T, Hattori F, Yamada M, Yoshikawa T
J Infect Chemother
. 2024 Dec;
31(2):102572.
PMID: 39631672
Introduction: We evaluated the application of a newly improved enzyme immunoassay (EIA) kit, Mumps IgG Seiken®, by comparing antibody responses to different EIA kits, and neutralization tests (NTs), using clinical...
8.
Yoshikane A, Miura H, Shima S, Matsunaga M, Ishimaru S, Higashimoto Y, et al.
Emerg Infect Dis
. 2024 Nov;
30(12):2476-2482.
PMID: 39592249
An increase in the number of herpes zoster patients has been reported since universal varicella immunization was introduced, perhaps because of reduced opportunities for varicella patients to experience the natural...
9.
Furukawa G, Yoshikane A, Ishihara N, Noda S, Katsuno M, Yoshikawa T
Pediatr Int
. 2024 Nov;
66(1):e15828.
PMID: 39582127
No abstract available.
10.
Fukuda S, Kugita M, Kumamoto K, Akari Y, Higashimoto Y, Nagao S, et al.
Viruses
. 2024 Aug;
16(8).
PMID: 39205172
The live attenuated human rotavirus vaccine strain RIX4414 (Rotarix) is used worldwide to prevent severe rotavirus-induced diarrhea in infants. This strain was attenuated through the cell culture passaging of its...